SYK and diffuse large B-cell lymphoma: There is also evidence of cross-communication with the BCR pathway triggered by mutated MyD88 through the activation of the BCR-signaling component SYK (spleen tyrosine kinase) in WM and activated B-cell diffuse large B-cell lymphoma (ABC DLBCL) cells [31].